Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on: August 28,2024

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on:August 28,2024

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on: May 23,2024

Tracking the epigenetic evolution of a cancer, cell by cell

by Weill Cornell Medical CollegeDr. Dan Landau. Credit: Rene PerezA powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables

Updated on:May 23,2024

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c

Updated on: March 06,2024

Novel silver compounds offer a potential cancer treatment breakthrough

by Marianne J. Cronjé And Reinout Meijboom,The ConversationOesophageal cancer cells before the silver-based compounds have been added.The development of chemotherapeutic drugs to treat various c

Updated on:March 06,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on: September 10,2024

Old chemo drug, new pancreatic cancer therapy?

Updated on:September 10,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on: March 30,2024

Researchers discover molecule that promotes production of cancer cells in triple-negative breast cancer

byHiroshima UniversityHiroshima University researchers found that AIbZIP is highly upregulated in triple negative breast cancer (TNBC). AIbZIP induces hyper proliferation of TNBC cells by promot

Updated on:March 30,2024

Researchers develop new software for unlocking cancer's ancestry

by Nick Wurm,Cold Spring Harbor LaboratoryCredit: Pixabay/CC0 Public DomainCould knowing where your ancestors came from be the key to better cancer treatments? Maybe, but where would that key fi

Updated on: February 03,2024

Researchers develop new software for unlocking cancer's ancestry

by Nick Wurm,Cold Spring Harbor LaboratoryCredit: Pixabay/CC0 Public DomainCould knowing where your ancestors came from be the key to better cancer treatments? Maybe, but where would that key fi

Updated on:February 03,2024

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more

Updated on: February 18,2024

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more

Updated on:February 18,2024

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell chang

Updated on: September 28,2024

Tumor-induced B cell changes reveal potential biomarker for treatment response in triple negative breast cancer

byBaylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell chang

Updated on:September 28,2024

Staying safe in the sun — a dermatologist helps separate facts from hype

by University of California, San FranciscoCredit: Elena ZhukovaSkin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers c

Updated on: April 20,2024

Staying safe in the sun — a dermatologist helps separate facts from hype

by University of California, San FranciscoCredit: Elena ZhukovaSkin cancer is the number-one cancer diagnosis in the United States – it's more common than breast, prostate, and lung cancers c

Updated on:April 20,2024

Deadly 'two-faced' protein drives cancer growth, cripples T-cell avengers

by Delthia Ricks , Medical XpressScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDScientists have deciphered a key st

Updated on: April 09,2024

Deadly 'two-faced' protein drives cancer growth, cripples T-cell avengers

by Delthia Ricks , Medical XpressScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDScientists have deciphered a key st

Updated on:April 09,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on: May 05,2024

Discovery of hybrid cancer cells reveals how disease spreads

by Aisling Irwin, From Horizon Magazine,Horizon: The EU Research & Innovation MagazineStudies show that hybrid cancer cells (in yellow) combine properties of different cells which can make t

Updated on:May 05,2024

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on: January 29,2024

No increased cancer risk found in rheumatology patients with history of malignancy taking DMARDS and TNF inhibitors

byAmerican College of RheumatologyFlowchart of patients included in the study. Credit: Cancer Risk with Biologic and Targeted Synthetic DMARDs in Patients with Rheumatic Diseases and Previous Ma

Updated on:January 29,2024